Novel Heart Disease Diagnostic Would Measure Risk by Testing the Gut

The saying that the way to a man’s heart is through the stomach might be true in more ways than one. Diagnostics company LipoScience is developing a new cardiovascular disease test that would use gut flora as a biomarker for cardiovascular risks.
MedCity News